business
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
Veracyte stock price target maintained at $42 by Canaccord on study results
Investing.com
Canaccord raises Waldencast stock price target on Obagi sale
Investing.com
UBS raises Caterpillar stock price target to $900 on strong Q1 beat
Investing.com
Freedom Broker raises i-80 Gold stock price target on stronger Q1
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop